Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Region (North America, APAC, Europe), And Segment Forecasts, 2021 - 2028

Table of Content

Chapter 1 Report Scope
1.1 Market Segmentation
1.2 Regional Scope
Chapter 2 Market Definition
2.1 Equipment
2.1.1 Therapeutic
2.1.1.1 Home respiratory therapy
2.1.1.2 Insulin delivery
2.1.1.3 Home IV (intravenous) pumps
2.1.1.4 Home dialysis equipment
2.1.2 Diagnostics
2.1.2.1 Diabetic care unit
2.1.2.2 Blood pressure monitors
2.1.2.3 Multi parameter diagnostic monitors
2.1.2.4 Home pregnancy and fertility kits
2.1.2.5 Apnea and sleep monitors
2.1.2.6 Holter monitors
2.1.2.7 Heart rate meters
2.1.3 Mobility Assist Equipment
2.1.3.1 Wheelchair
2.1.3.2 Home medical furniture
2.1.3.3 Walking assist devices
2.2 Service
2.2.1 Skilled home healthcare
2.2.2 Unskilled home healthcare
2.3 Estimates and Forecast Timeline
Chapter 3 Methodology
3.1 Research Methodology
3.1.1 Information procurement
3.1.2 Purchased Database
3.1.3 GVR’s Internal Database
3.1.4 Secondary Sources
3.1.5 Primary Research
3.2 Information or Data Analysis
3.2.1 Data Analysis Models
3.3 Market Formulation & Validation
3.4 Region Wise Market Calculation
3.4.1 Region Wise Market: Base Estimates
3.4.2 Global Market: CAGR Calculation
3.5 Region Based Segment Share Calculation
3.6 Model Details
3.6.1 Commodity flow analysis
3.6.2 Volume price analysis
3.7 List of Secondary Sources
3.8 List of Abbreviations
Chapter 4 Objectives
4.1 Objective - 1
4.2 Objective - 2
4.3 Objective - 3
Chapter 5 Executive Summary
Chapter 6 Industry Outlook
6.1 Market Lineage outlook
6.1.1 Parent market outlook
6.1.2 Related/ancillary market outlook
6.2 User Perspective Analysis
6.2.1 Consumer Behavior Analysis
6.3 Business Segment Trends
6.3.1 Product business analysis
6.3.2 regional business analysis
6.4 Market Dynamics
6.4.1 Market driver analysis
6.4.1.1 Home healthcare as a cost-effective alternative
6.4.1.2 Growing geriatric population
6.4.1.3 Hospital solution providers penetrating the home healthcare market
6.4.1.4 Growing prevalence of target diseases, especially Alzheimer’s and dementia
6.4.1.5 Companies are expanding operations in other cities
6.4.1.6 Advancement in technology
6.4.2 Market restraint analysis
6.4.2.1 Lower remunerations
6.4.2.2 Shortage of skilled healthcare staff
6.4.2.3 Complicated reimbursement framework and reimbursement cuts
6.5 Penetration & Growth Prospect Mapping
6.6 Business Environment Analysis tools
6.6.1 SWOT Analysis, by PEST
6.6.1.1 Political & legal
6.6.1.2 Economic
6.6.1.3 Technological & social
6.6.2 Porter’s five forces analysis
6.6.2.1 Threat of new entrants: Moderate
6.6.2.2 Bargaining power of buyers : Moderate
6.6.2.3 Competitive rivalry : High
6.6.2.4 Bargaining power of suppliers : Moderate
6.6.2.5 Threat of substitutes : Moderate
6.6.3 Industry Analysis - Ansoff Matrix
Chapter 7 Regulatory & Political Forces
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.2 Europe
7.3 Asia
Chapter 8 Reimbursement Scenario
8.1 U.S.
8.2 Canada
8.3 UK
8.4 Germany
8.5 France
8.6 Italy
8.7 Spain
8.8 Netherlands
8.9 Japan
8.10 Australia
8.11 Singapore
8.12 Brazil
Chapter 9 Home Healthcare Market: Component Analysis
9.1 Home Healthcare Market: Component Movement Analysis
9.2 Equipment
9.2.1 Equipment market, 2016 - 2028 (USD Million)
9.2.2 Therapeutic
9.2.2.1 Therapeutic market, 2016 - 2028 (USD Million)
9.2.2.2 Home respiratory therapy
9.2.2.2.1 Home respiratory therapy market, 2016 - 2028 (USD Million)
9.2.2.3 Insulin delivery
9.2.2.3.1 Insulin delivery market, 2016 - 2028 (USD Million)
9.2.2.4 Home intravenous pumps
9.2.2.4.1 Home IV pumps market, 2016 - 2028 (USD Million)
9.2.2.5 Home dialysis equipment
9.2.2.5.1 Home dialysis equipment market, 2016 - 2028 (USD Million)
9.2.2.6 Other therapeutic equipment
9.2.2.6.1 Other therapeutic equipment market, 2016 - 2028 (USD Million)
9.2.3 Diagnostics
9.2.3.1 Diagnostics market, 2016 - 2028 (USD Million)
9.2.3.2 Diabetic care unit
9.2.3.2.1 Diabetic care unit market, 2016 - 2028 (USD Million)
9.2.3.3 Blood pressure monitors
9.2.3.3.1 Blood pressure monitors market, 2016 - 2028 (USD Million)
9.2.3.4 Multi parameter diagnostic monitors
9.2.3.4.1 Multi parameter diagnostic monitors market, 2016 - 2028 (USD Million)
9.2.3.5 Home pregnancy and fertility kits
9.2.3.5.1 Home pregnancy and fertility kits market, 2016 - 2028 (USD Million)
9.2.3.6 Apnea and sleep monitors
9.2.3.6.1 Apnea and sleep monitors market, 2016 - 2028 (USD Million)
9.2.3.7 Holter monitors
9.2.3.7.1 Holter monitors market, 2016 - 2028 (USD Million)
9.2.3.8 Heart rate meters
9.2.3.8.1 Heart rate meters market, 2016 - 2028 (USD Million)
9.2.3.9 Others diagnostic equipment
9.2.3.9.1 Other Diagnostic Equipment market, 2016 - 2028 (USD Million)
9.2.4 Mobility assist equipment
9.2.4.1 Mobility assist equipment market, 2016 - 2028 (USD Million)
9.2.4.2 Wheelchair
9.2.4.2.1 Wheelchair market, 2016 - 2028 (USD Million)
9.2.4.3 Home medical furniture
9.2.4.3.1 Home medical furniture market, 2016 - 2028 (USD Million)
9.2.4.4 Walking assist devices
9.2.4.4.1 Walking assist devices market, 2016 - 2028 (USD Million)
9.3 Services
9.3.1 Services market, 2016 - 2028 (USD Million)
9.3.2 Skilled home healthcare
9.3.2.1 Skilled home healthcare market, 2016 - 2028 (USD Million)
9.3.2.2 Physician primary care
9.3.2.2.1 Physician primary care market, 2016 - 2028 (USD Million)
9.3.2.3 Nursing care
9.3.2.3.1 Nursing care market, 2016 - 2028 (USD Million)
9.3.2.4 Physical/occupational/speech therapy
9.3.2.4.1 Physical/occupational/speech therapy market, 2016 - 2028 (USD Million)
9.3.2.5 Nutritional support
9.3.2.5.1 Nutritional support market, 2016 - 2028 (USD Million)
9.3.2.6 Hospice & palliative
9.3.2.6.1 Hospice & palliative market, 2016 - 2028 (USD Million)
9.3.2.7 Other skilled home healthcare
9.3.2.7.1 Other skilled home healthcare market, 2016 - 2028 (USD Million)
9.3.3 Unskilled home healthcare
9.3.3.1 Unskilled home healthcare market, 2016 - 2028 (USD Million)
Chapter 10 Home Healthcare Market: Regional Outlook
10.1 Home Healthcare Market Share by Region, 2020 & 2028
10.2 Regional SWOT Analysis
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 MEA
10.3 North America
10.3.1 North America home healthcare market, 2016 - 2028 (USD Million)
10.3.2 U.S.
10.3.2.1 U.S. home healthcare market, 2016 - 2028 (USD Million)
10.3.3 Canada
10.3.3.1 Canada home healthcare market, 2016 - 2028 (USD Million)
10.4 Europe
10.4.1 Europe home healthcare market, 2016 - 2028 (USD Million)
10.4.2 U.K.
10.4.2.1 U.K. home healthcare market, 2016 - 2028 (USD Million)
10.4.3 Germany
10.4.3.1 Germany home healthcare market, 2016 - 2028 (USD Million)
10.4.4 Italy
10.4.4.1 Italy home healthcare market, 2016 - 2028 (USD Million)
10.4.5 Spain
10.4.5.1 Spain home healthcare market, 2016 - 2028 (USD Million)
10.4.6 Sweden
10.4.6.1 Sweden home healthcare market, 2016 - 2028 (USD Million)
10.4.7 France
10.4.7.1 France home healthcare market, 2016 - 2028 (USD Million)
10.4.8 Russia
10.4.8.1 Russia home healthcare market, 2016 - 2028 (USD Million)
10.4.9 The Netherlands
10.4.9.1 The Netherlands home healthcare market, 2016 - 2028 (USD Million)
10.5 Asia Pacific
10.5.1 Asia Pacific home healthcare market, 2016 - 2028 (USD Million)
10.5.2 Japan
10.5.2.1 Japan home healthcare market, 2016 - 2028 (USD Million)
10.5.3 China
10.5.3.1 China home healthcare market, 2016 - 2028 (USD Million)
10.5.4 India
10.5.4.1 India home healthcare market, 2016 - 2028 (USD Million)
10.5.5 Australia
10.5.5.1 Australia home healthcare market, 2016 - 2028 (USD Million)
10.5.6 Singapore
10.5.6.1 Singapore home healthcare market, 2016 - 2028 (USD Million)
10.5.7 Malaysia
10.5.7.1 Malaysia home healthcare market, 2016 - 2028 (USD Million)
10.5.8 Thailand
10.5.8.1 Thailand home healthcare market, 2016 - 2028 (USD Million)
10.5.9 Philippines
10.5.9.1 Philippines home healthcare market, 2016 - 2028 (USD Million)
10.5.10 South Korea
10.5.10.1 South Korea home healthcare market, 2016 - 2028 (USD Million)
10.6 Latin America
10.6.1 Latin America home healthcare market, 2016 - 2028 (USD Million)
10.6.2 Brazil
10.6.2.1 Brazil home healthcare market, 2016 - 2028 (USD Million)
10.6.3 Mexico
10.6.3.1 Mexico home healthcare market, 2016 - 2028 (USD Million)
10.6.4 Argentina
10.6.4.1 Argentina home healthcare market, 2016 - 2028 (USD Million)
10.7 MEA
10.7.1 MEA home healthcare market, 2016 - 2028 (USD Million)
10.7.2 South Africa
10.7.2.1 South Africa home healthcare market, 2016 - 2028 (USD Million)
10.7.3 Saudi Arabia
10.7.3.1 Saudi Arabia home healthcare market, 2016 - 2028 (USD Million)
10.7.4 Oman
10.7.4.1 Oman home healthcare market, 2016 - 2028 (USD Million)
10.7.5 UAE
10.7.5.1 UAE home healthcare market, 2016 - 2028 (USD Million)
10.7.6 Egypt
10.7.6.1 Egypt home healthcare market, 2016 - 2028 (USD Million)
Chapter 11 Competitive & Vendor Landscape
11.1 Participant Categorization
11.1.1 Innovators
11.1.1.1 Koninklijke Philips N.V.
11.1.1.2 Medtronic
11.1.1.3 Baxter
11.1.1.4 Invacare Corporation
11.1.1.5 Medline Industries Inc.
11.1.2 Market Leaders
11.1.2.1 Home healthcare equipment market
11.1.2.2 Home healthcare services market
11.1.2.2.1 List of few home healthcare service providers in the U.S.
11.1.2.2.2 List of few home healthcare service providers in Canada
11.1.2.2.3 List of few home healthcare service providers in UK
11.1.2.2.4 List of few home healthcare service providers in the Netherlands
11.1.2.2.5 List of few home healthcare service providers in Singapore
11.1.2.2.6 List of few home healthcare service providers in Australia
11.1.3 Strategy Mapping
11.1.3.1 Launch of new products
11.1.3.2 Acquisition
11.1.3.3 Expansion
11.1.3.4 Agreements, collaborations, partnerships
11.1.3.5 Others (realignment, divestment, market penetration)
11.1.3.6 Strategic initiatives
11.2 Recent Development & Impact Analysis, by Key Market Participants
Chapter 12 Company Profiles: Service Providers
12.1 KINDRED HEALTHCARE, INC.
12.1.1 Company overview
12.1.2 Financial performance
12.1.3 Service benchmarking
12.1.4 Strategic initiatives
12.2 ALMOST FAMILY, INC.
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Service benchmarking
12.2.4 Strategic initiatives
12.3 NATIONAL HEALTHCARE CORPORATION
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Service benchmarking
12.3.4 Strategic initiatives
12.4 CHUBB FIRE & SECURITY PTY LTD
12.4.1 Company overview
12.4.2 Financial performance
12.4.3 Service benchmarking
12.4.4 Strategic initiatives
12.5 GENTIVA HEALTH SERVICES, INC.
12.5.1 Company overview
12.5.2 Financial performance
12.5.3 Service benchmarking
12.5.4 Strategic initiatives
12.6 MEDCO HOME HEALTHCARE, INC.
12.6.1 Company overview
12.6.2 Service benchmarking
12.7 ADDUS HOMECARE
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Service benchmarking
12.7.4 Strategic initiatives
12.8 BROOKDALE SENIOR LIVING INC.
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Services benchmarking
12.8.4 Strategic initiatives
12.9 SUNRISE StRATFORD, LP (SUNRISE SENIOR LIVING, LLC)
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Services benchmarking
12.9.4 Strategic initiatives
12.10 GENESIS HEALTHCARE, INC.
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Service benchmarking
12.10.4 Strategic initiatives
12.11 EXTENDICARE, INC.
12.11.1 Company overview
12.11.2 Financial performance
12.11.3 Service benchmarking
12.11.4 Strategic initiatives
12.12 CAPITAL SENIOR LIVING CORPORATION
12.12.1 Company overview
12.12.2 Financial performance
12.12.3 Services benchmarking
12.12.4 Strategic initiatives
12.13 DIVERSICARE HEALTHCARE SERVICES, INC.
12.13.1 Company overview
12.13.2 Financial performance
12.13.3 Services benchmarking
12.13.4 Strategic initiatives
12.14 HOME INSTEAD, INC.
12.14.1 Company overview
12.14.2 Services benchmarking
12.14.3 Strategic initiatives
12.15 SENIOR CARE CENTERS OF AMERICA
12.15.1 Company overview
12.15.2 Services benchmarking
12.15.3 Strategic initiatives
12.16 ATRIA SENIOR LIVING, INC.
12.16.1 Company overview
12.16.2 Services benchmarking
12.16.3 Strategic initiatives
12.17 AMEDISYS, INC.
12.17.1 Company overview
12.17.2 Financial performance
12.17.3 Service benchmarking
12.17.4 Strategic initiatives
Chapter 13 Company Profiles: Suppliers
13.1 B. BRAUN MELSUNGEN AG
13.1.1 Company overview
13.1.2 Financial performance
13.1.3 Product benchmarking
13.1.4 Strategic initiatives
13.2 ABBOTT
13.2.1 Company overview
13.2.2 Financial performance
13.2.3 Product benchmarking
13.2.4 Strategic initiatives
13.3 SUNRISE MEDICAL
13.3.1 Company overview
13.3.2 Financial performance
13.3.3 Product benchmarking
13.3.4 Strategic initiatives
13.4 3M HEALTHCARE
13.4.1 Company overview
13.4.2 Financial performance
13.4.3 Product benchmarking
13.4.4 Strategic initiatives
13.5 BAXTER INTERNATIONAL INC.
13.5.1 Company overview
13.5.2 Financial performance
13.5.3 Product benchmarking
13.5.4 Strategic initiatives
13.6 MEDTRONIC PLC
13.6.1 Company overview
13.6.2 Financial performance
13.6.3 Product benchmarking
13.6.4 Strategic initiatives
13.7 CARDINAL HEALTH INC.
13.7.1 Company overview
13.7.2 Financial performance
13.7.3 Product benchmarking
13.7.4 Strategic initiatives
13.8 F. HOFFMANN-LA ROCHE AG
13.8.1 Company overview
13.8.2 Financial performance
13.8.3 Product benchmarking
13.8.4 Strategic initiatives
13.9 AIR LIQUIDE
13.9.1 Company overview
13.9.2 Financial performance
13.9.3 Product benchmarking
13.9.4 Strategic initiatives.
13.10 NXSTAGE MEDICAL, INC. (FRESENIUS MEDICAL CARE)
13.10.1 Company overview
13.10.2 Financial performance
13.10.3 Product benchmarking
13.10.4 Strategic initiatives
13.11 ARKRAY, INC.
13.11.1 Company overview
13.11.2 Product benchmarking
13.11.3 Strategic Initiatives
13.12 BECTON, DICKINSON AND COMPANY
13.12.1 Company overview
13.12.2 Financial performance
13.12.3 Product benchmarking
13.12.4 Strategic initiatives
13.13 OMRON HEALTHCARE, INC.
13.13.1 Company overview
13.13.2 Financial performance
13.13.3 Product benchmarking
13.13.4 Strategic initiatives
13.14 DRIVE DEVILBISS HEALTHCARE
13.14.1 Company overview
13.14.2 Financial performance
13.14.3 Product benchmarking
13.14.4 Strategic initiatives
13.15 GE HEALTHCARE
13.15.1 Company overview
13.15.2 Financial performance
13.15.3 Product benchmarking
13.15.4 Strategic initiatives
13.16 MEDLINE INDUSTRIES, INC.
13.16.1 Company overview
13.16.2 Financial performance
13.16.3 Product benchmarking
13.16.4 Strategic initiatives
13.17 KONINKLIJKE PHILIPS N.V.
13.17.1 Company overview
13.17.2 Financial performance
13.17.3 Product benchmarking
13.17.4 Strategic initiatives
13.18 HILL-ROM, INC.
13.18.1 Company overview
13.18.2 Financial performance
13.18.3 Product benchmarking
13.18.4 Strategic initiatives
13.19 JOHNSON & JOHNSON SERVICES, INC.
13.19.1 Company overview
13.19.2 Financial performance
13.19.3 Product benchmarking
13.19.4 Strategic initiatives
13.20 LINDE HEALTHCARE
13.20.1 Company overview
13.20.2 Financial performance
13.20.3 Product benchmarking
13.20.4 Strategic initiatives
13.21 ACELITY
13.21.1 Company overview
13.21.2 Product benchmarking
13.21.3 Strategic initiatives
13.22 VYGON
13.22.1 Company overview
13.22.2 Financial performance
13.22.3 Product benchmarking
13.23 TELEFLEX, INC.
13.23.1 Company overview
13.23.2 Financial performance
13.23.3 Product benchmarking
13.24 MOOG INC.
13.24.1 Company overview
13.24.2 Financial performance
13.24.3 Product benchmarking
13.25 INTERSURGICAL LTD.
13.25.1 Company overview
13.25.2 Product benchmarking
13.26 FRESENIUS KABI AG.
13.26.1 Company overview
13.26.2 Financial performance
13.26.3 Product benchmarking
13.26.4 Strategic initiatives
13.27 BAYER HEALTHCARE
13.27.1 Company overview
13.27.2 Financial performance
13.27.3 Product benchmarking
13.27.4 Strategic initiatives
13.28 GF HEALTH PRODUCTS, INC.
13.28.1 Company overview
13.28.2 Financial performance
13.28.3 Product benchmarking
13.28.4 Strategic initiatives
Chapter 14 Recommendations